General Information of the Compound
Compound ID |
CP0449162
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
6-[[2-[4-[(E)-2-(2,2-difluoro-12-thiophen-2-yl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-4-yl)ethenyl]phenoxy]acetyl]amino]-N-[2-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]ethyl]hexanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C43H48BF2N5O5S
|
||||||||||||||||||
Molecular Weight |
795.762
|
||||||||||||||||||
Canonical SMILES |
OC(CNCCNC(=O)CCCCCNC(=O)COc1ccc(\C=C\c2ccc3C=C4C=CC(c5cccs5)=[N+]4[B-](F)(F)n23)cc1)COc1ccccc1CC=C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C43H48BF2N5O5S/c1-2-9-33-10-5-6-11-40(33)56-30-37(52)29-47-25-26-49-42(53)13-4-3-7-24-48-43(54)31-55-38-21-15-32(16-22-38)14-17-34-18-19-35-28-36-20-23-39(41-12-8-27-57-41)51(36)44(45,46)50(34)35/h2,5-6,8,10-12,14-23,27-28,37,47,52H,1,3-4,7,9,13,24-26,29-31H2,(H,48,54)(H,49,53)/b17-14+
Show/Hide
|
||||||||||||||||||
InChIKey |
IMRFACHFIDBCFZ-SAPNQHFASA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor